Epicore Biosystems, a leader in digital health solutions, has successfully raised $26 million in a Series B funding round. The investment was led by the Steele Foundation for Hope and aims to accelerate the global adoption of Epicore’s sweat-sensing wearables and cloud analytics platform. With this funding, the company plans to expand into new biomarker targets relevant to kidney health, women’s health, malnutrition, and environmental toxin exposure.

Addressing Global Health Risks

Extreme heat exposure is a growing concern worldwide, posing significant risks to vulnerable populations, including industrial workers, children, and pregnant women. The combined effects of heat stress and environmental toxins are contributing to increasing acute and chronic health conditions. Epicore's sweat-sensing technology provides real-time insights into hydration, stress, nutrition, and overall wellness, helping to mitigate these risks.

Innovative Wearable Technology

Epicore has developed a new class of biochemical-sensing wearables designed to monitor sweat composition and fluid loss non-invasively. These devices work alongside traditional digital biomarkers to alert wearers of potential dehydration, heat injury, or malnutrition risks. By leveraging advanced metabolic health insights, Epicore’s technology delivers data-driven recommendations tailored to individual needs.

CEO’s Vision for the Future

Dr. Roozbeh Ghaffari, CEO and co-founder of Epicore Biosystems, emphasized the transformative potential of their technology. He highlighted how their wearables empower users in sports, fitness, and industrial sectors by unlocking critical health and wellness insights. With the Series B funding, Epicore aims to extend its global reach and accelerate the validation of new biomarkers that will shape the future of personalized hydration and wellness strategies.

Product Line and Industry Collaborations

Epicore’s suite of sweat-sensing wearables includes the Gx Sweat Patch, which was commercialized in collaboration with PepsiCo and Gatorade. Other offerings include the Discovery Patch® Sweat Collection System, an FDA Class I device, and the Connected Hydration wearable and cloud platform, which is tailored for industrial workers. These products collectively address the growing demand for personalized health solutions across various sectors.

Investor Confidence and Support

Joe Exner, CEO of the Steele Foundation for Hope, underscored the alignment between Epicore’s mission and the foundation’s commitment to enhancing global quality of life. He expressed confidence in the company’s innovative sweat-monitoring technology and its potential to address pressing health challenges. The foundation’s backing reflects a broader recognition of the need for connected health solutions in response to climate change and environmental stressors.

Expanding Market Reach

Since completing its Series A funding over three years ago, Epicore has expanded beyond the sports and fitness sector, achieving a 24-fold increase in its customer base. The company now serves leading multinational enterprises across industries such as energy, construction, manufacturing, and aviation. As health and environmental disparities grow, the demand for digital solutions that measure advanced biometrics and provide personalized recommendations continues to drive the health tech revolution.

Epicore Biosystems is at the forefront of innovation in digital health, leveraging sweat-sensing wearables to enhance wellness and hydration management. With its latest Series B funding, the company is poised for significant expansion, bringing its technology to a broader audience and validating new biomarkers for improved health monitoring. As the intersection of technology and health continues to evolve, Epicore’s solutions are set to play a critical role in addressing global health challenges.